Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Sutton

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|February 1, 1986
Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group StudyR E Slayton, J A Blessing, G P Sutton, et al.
Radiology|October 1, 1987
Ovarian carcinoma: adjuvant treatment with P-32S Reddy, G P Sutton, F B Stehman, et al.
Seminars in Oncology|April 1, 1990
Gynecologic Oncology Group experience with ifosfamideG P Sutton, J A Blessing, G Photopulos, et al.
In Vivo (Athens, Greece)|November 1, 1994
Synergistic cytotoxic and antitumor effects of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cellsN B Hornback, R N Shen, G P Sutton, et al.
Gynecologic Oncology|April 1, 1997
Collagenase expression in ovarian cancer cell linesD H Moore, B Allison, K Y Look, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignanciesG P Sutton, J A Blessing, G Photopulos, et al.
Cancer|March 1, 1994
Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group studyG P Sutton, J A Blessing, H D Homesley, et al.
Indiana Medicine : the Journal of the Indiana State Medical Association|April 1, 1988
The use of Rh immune globulin: a reviewG P Sutton, A Jay, Y S Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group StudyG P Sutton, J A Blessing, H D Homesley, et al.
Seminars in Oncology|February 1, 1989
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studiesG P Sutton, J A Blessing, G Photopulos, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|February 1, 1986
Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group StudyR E Slayton, J A Blessing, G P Sutton, et al.
Radiology|October 1, 1987
Ovarian carcinoma: adjuvant treatment with P-32S Reddy, G P Sutton, F B Stehman, et al.
Seminars in Oncology|April 1, 1990
Gynecologic Oncology Group experience with ifosfamideG P Sutton, J A Blessing, G Photopulos, et al.
In Vivo (Athens, Greece)|November 1, 1994
Synergistic cytotoxic and antitumor effects of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cellsN B Hornback, R N Shen, G P Sutton, et al.
Gynecologic Oncology|April 1, 1997
Collagenase expression in ovarian cancer cell linesD H Moore, B Allison, K Y Look, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignanciesG P Sutton, J A Blessing, G Photopulos, et al.
Cancer|March 1, 1994
Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group studyG P Sutton, J A Blessing, H D Homesley, et al.
Indiana Medicine : the Journal of the Indiana State Medical Association|April 1, 1988
The use of Rh immune globulin: a reviewG P Sutton, A Jay, Y S Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group StudyG P Sutton, J A Blessing, H D Homesley, et al.
Seminars in Oncology|February 1, 1989
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studiesG P Sutton, J A Blessing, G Photopulos, et al.
Pageof 11